Q-Switched Ruby Laser Treatment for Postsclerotherapy Hyperpigmentation

Tafazzoli, Alireza; Rostan, Elizabeth F.; Goldman, Mitchel P.

doi:10.1046/j.1524-4725.2000.99268.x

Cited by 53 publications

(31 citation statements)

References 27 publications

(48 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Q‐switched ruby laser has been proposed for the treatment of PIH. Improvement of postsclerotherapy hyperpigmentation was reported with QSRL 694 nm treatment in one study . On the other hand, QSRL was ineffective in another study on eight patients addressing either melasma or PIH.…”

Section: Clinical Indicationsmentioning

confidence: 93%

Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology

Passeron

Genedy

Salah

et al. 2019

Acad Dermatol Venereol

View full text Add to dashboard Cite

Background Lasers and intense pulsed light sources (IPLS) are proposed for the treatment of many pigmentary disorders. They are sometimes considered as magic tools able to remove any type of lesions. Although being the best option for several hyperpigmented lesions, they can also worsen some conditions and have potential side‐effects. Objective The aim of this review was to give evidence‐based recommendations for the use of lasers and IPLS in the treatment of hyperpigmented lesions. Methods These recommendations were produced for the European Society of Laser Dermatology by a consensus panel made up of experts in the field of pigment laser surgery. Recommendations on the use of lasers and light treatments were made based on the quality of evidence for efficacy, safety, tolerability, cosmetic outcome, patient satisfaction/preference and, where appropriate, on the experts' opinion. Results Lasers and IPLS are very effective for treating many hyperpigmented lesions such as lentigos, dermal hypermelanocytosis or heavy metal depositions. In the other hand, they have to be considered with great caution for other disorders, such as café au lait macules, melasma or postinflammatory hyperpigmentation. After making the correct diagnosis, if lasers or IPLS are indicated, the optimal wavelengths and parameters will be chosen taking into account the skin phototype, origin and depth of the target pigments. Conclusion Although potentially very effective, lasers and IPLS cannot be proposed for all types of hyperpigmented lesions. In all cases, precise recognition of the disorder is mandatory for choosing between these devices and other therapeutic approaches.

show abstract

Section: Clinical Indicationsmentioning

confidence: 93%

Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology

Passeron

Genedy

Salah

et al. 2019

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…Pallor may improve with erythropoietin treatment and correction of anemia . Currently, there are not any first line treatments for hemosiderin deposits, however, case studies demonstrate successful treatment of hemosiderin containing hyperpigmentation with the Q‐Switched (QS) 650‐nm Nd:YAG laser, the 50‐ns QS 755‐nm alexandrite laser, the QS ruby laser and the 700‐picosecond alexandrite laser . This therapy shows promise but needs further testing.…”

Section: Nonspecificmentioning

confidence: 99%

Dermatologic manifestations in end stage renal disease

Blaha

Nigwekar

Combs

et al. 2018

Hemodialysis International

View full text Add to dashboard Cite

Skin manifestations are commonly seen in end stage renal disease (ESRD). Skin involvement in this population can be extensive and dramatically worsen quality of life. Close observation of the skin and nails of ESRD patients by clinicians allows for timely diagnosis and treatment, which ultimately improves quality of life and reduces mortality. In this article we focus on the cutaneous changes most commonly seen in ESRD patients. PubMed/Medline database search was done for published literature on skin manifestations in ESRD patients. All the available literature was reviewed and relevant articles were used to discuss about clinical features, pathogenesis, histology and treatment of each skin disorder in ESRD patients. Most commonly encountered skin manifestations in patients with ESRD are pruritus, xerosis, pigmentation changes, nail changes, perforating disorders, calcifying disorders, bullous dermatoses and nephrogenic systemic fibrosis. Skin manifestations in ESRD can be difficult to treat and multiple comorbidities in this patient population can exacerbate these disorders. Many of the treatment options are experimental with evidence largely derived from the case reports and small clinical trials. More large‐scale trials are needed to firmly establish evidence based treatment guidelines. Prompt evaluation and management of these disorders improve morbidity and quality of life in ESRD patients.

show abstract

“…Taylor et al . [34] treated eight patients with melasma or PIH with Q S ruby laser pulses (694 nm, 40 ns) at fluences of 15–7.5 J/cm 2 and did not find any improvement, whereas Tafazzoli and colleagues[56] observed 75–100% of improvement in 58% of patients of post-sclerotherapy hyperpigmentation treated with QS ruby laser. Cho and colleagues treated three patients with PIH with QS Nd:YAG 1064 nm laser at fluences of 1.9–2.6 J/cm 2 and five sessions and good results.…”

Section: Pih and Lasermentioning

confidence: 99%

Lasers for treatment of melasma and post-inflammatory hyperpigmentation

Arora

Sarkar

Garg³

et al. 2012

J Cutan Aesthet Surg

View full text Add to dashboard Cite

Hyperpigmentary disorders, especially melasma and post-inflammatory hyperpigmentation (PIH), cause significant social and emotional stress to the patients. Although many treatment modalities have been developed for melasma and PIH, its management still remains a challenge due to its recurrent and refractory nature. With the advent of laser technology, the treatment options have increased especially for dermal or mixed melasma. To review the literature on the use of cutaneous lasers for melasma and PIH. We carried out a PubMed search using following terms “lasers, IPL, melasma, PIH”. We cited the use of various lasers to treat melasma and PIH, including Q-switched Nd:YAG, Q-switched alexandrite, pulsed dye laser, and various fractional lasers. We describe the efficacy and safety of these lasers for the treatment of hyperpigmentation. Choosing the appropriate laser and the correct settings is vital in the treatment of melasma. The use of latter should be restricted to cases unresponsive to topical therapy or chemical peels. Appropriate maintenance therapy should be selected to avoid relapse of melasma.

show abstract

Q-Switched Ruby Laser Treatment for Postsclerotherapy Hyperpigmentation

Abstract: Our impression is that given a choice of lasers, the Q-switched ruby laser provides the greatest efficacy for treating postsclerotherapy hyperpigmentation.

Cited by 53 publications

References 27 publications

Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology

Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology

Dermatologic manifestations in end stage renal disease

Lasers for treatment of melasma and post-inflammatory hyperpigmentation

Contact Info

Product

Resources

About